DIGIPHARM - Bringing value-based healthcare to life using blockchain technology

Digipharm bringing value-based healthcare to life and in the manner of utilise innovative blockchain technology, Digipharm will overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and bypass infrastructural limitations to drive value improvement, incentivise innovation and expedite the transformation to personalised healthcare.

Our Vision

To be the pioneer of sustainable and value-based healthcare delivery, innovative evidence generation and patient empowerment across the healthcare industry.

The Future of Healthcare

Value Based Care

Healthcare systems around the world are currently threatened by challenges unique to our time; unsustainable expenditure, ageing populations and the increasing prevalence of chronic diseases. The concept of value based healthcare proposes that payment for healthcare should be tied to the quality of care and the benefits it provides; switching from a ‘fee for service’ to a ‘fee for performance’ reimbursement model.

Innovative Pricing

Innovative pricing solutions such as value-based pricing offer an increasingly dynamic solution to address the uncertainty around the cost of treatment relative to patient outcomes. Such mechanisms reward manufacturers and providers for improving patient outcomes, incentivise innovation and encourage the transition to patient centric healthcare.

Pioneering Evidence Generation

Innovative evidence generation solutions are necessary to satisfy the requirement of relevant, timely and quality data to inform the provision of optimised value based healthcare. Circumventing the use of static or retrospective data will open the horizon to superior forecasting, confidence in decision making and global oversight with regards to current developments in an increasingly dynamic industry such as healthcare.

Our Flagship Solutions

Reimburse

Reimburse will eliminate the infrastructural barriers and automate the implementation of value based pricing agreements, no matter how complex, on a fully independent global platform; encouraging personalised reimbursement of health technology on a ‘fee for performance’ basis for the mutual benefit of patients, payers and manufacturers.

Accelerates access to high cost therapy
Incentivises innovation
Drastically reduces administrative costs

Insights

Insights is the first ever ‘live’ real world evidence repository and allows the utilisation of real world evidence (RWE) as soon as it becomes available. The availability of ‘live’ RWE will provide stakeholders with real time intelligence with which they can inform decision making and product development across the medicinal lifecycle.

Incentives for patients to contribute data
Significant cost savings compared to conventional RWE sources
Single platform for global evidence

Digipharm Token Information

Digipharm (DPH) tokens will be used to pay license fees / access on the Digipharm platform. Access fees will always be determined and fixed in USD value and the number of tokens required will depend on the type of access (producer, patient, payer or provider) combined with the necessary interaction form. The quantity of tokens required for such interactions may change, relative to the market value of the DPH.

Token Name: DPH
Total Supply: 100,000,000
Fixed (ERC-20)
Decimal: 18

Pre - Sale: 15,000,000 DPH

Base Price: 1.00 USD
Pre - Sale Length: 4 Weeks
Pre - Sale Discount: 35%
Main Sale: 50,000,000 DPH

Week 1: 25% Frozen 25 million token
Week 2: 15% Frozen 15 million token
Week 3: 10% Frozen 10 million token
Week 4: 1.00 USD

The Team

The Digipharm team is backed by some really amazingly talented brains. The CEO, Ahmed Abdulla had previous experience at really amazing place including International Healthcare Limited and the University of Liverpool. The CTO, Girisha Fernando comes on board with experience from different places like Portfolio Management. The rest of the team is well qualified and enthusiast to work on this idea.

Swisscom Blockchain are Digipharms' technical development partners for the development of our flagship solutions

Digipharm are strong believers in empowering patients with the custodianship and ownership of their personal data. Patients will be incentivised to share and contribute their health related data to inform decision making and health related research.

LINK

Website: https://www.digipharm.ch/

Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf

Telegram: https://t.me/digipharm

Facebook: https://www.facebook.com/digipharmteam/

Twitter: https://twitter.com/DigipharmTeam

My Account BTT : https://bitcointalk.org/index.php?action=profile;u=1215958

ETH Address: 0x3407e9b59137eccB7a9041CE476ab330468685Bf